HEATHER MAY ARSENAULT DO
Prescription History 1083174650
Hospitalist in Rockport, ME

Active since March 20, 2019PECOS EnrolledAccepts Medicare Assignment
6 GLEN COVE DR, ROCKPORT, ME 04856(207) 301-8542(207) 301-5277 Get Directions

NPPES record last updated: July 29, 2025. Verified against the NPPES registry weekly; last sync: August 02, 2026.

Record update history: Mar 17, 2025, Jun 26, 2024, Mar 20, 2019 (3 updates tracked since 2019).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for HEATHER MAY ARSENAULT DO, an active Hospitalist specialist practicing in Rockport, ME. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 13 documented patient claims. Among these therapy options, the most frequently utilized medication is Trelegy Ellipta, which accounts for 13 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
13
Total Claims
13
30-Day Fills
Trelegy Ellipta
Most Prescribed · 13 claims
View details
1 medication · 2023 Medicare Part D
Medicare Part D medications prescribed by HEATHER MAY ARSENAULT DO in 2023, with prescription volumes, average cost per fill, and ME state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other ME PrescribersVs. ME Avg
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$685.99▼ below ME avg Less than typical

About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed.

In 2023, this provider wrote 13 Medicare prescriptions for Trelegy Ellipta, about a third of the volume of the typical Maine prescriber of this medication (43). Medicare paid an average of $685.99 per fill, versus $964.73 statewide.

How often this provider prescribes it

This provider
13
ME average
43.0

This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$685.99
ME average
$964.73

This provider's average cost per fill is below the ME average for this medication.

13
30-Day Fills
standardized to 30-day supplies
390
Days of Medication
total across all patients in 2023
No medications match the current filters.
More than typical Typical Less than typical= prescription volume vs the average ME prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the ME average cost per fill.

About this data. The prescription history for HEATHER MAY ARSENAULT DO is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hospitalist prescribing approach at this Rockport, ME practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among ME prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.